Lipella Pharmaceuticals Inc. (LIPO)

Lipella Pharmaceuticals Revenue

In the year 2024, Lipella Pharmaceuticals had annual revenue of $536.36K with 19.29% growth. Lipella Pharmaceuticals had revenue of $173.67K in the quarter ending December 31, 2024, with 43.71% growth.

• Revenue (ttm): $536.36K
• Revenue Growth: +19.29%
• P/S Ratio: 4.79
• Revenue / Employee: $76,622
• Employees: 7
• Market Cap: 6.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	536.36K	86.74K	19.29%
Dec 31, 2023	449.62K	265.46K	144.15%
Dec 31, 2022	184.16K	-75.19K	-28.99%
Dec 31, 2021	259.35K	-702.34K	-73.03%
Dec 31, 2020	961.68K	266.94K	38.42%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.